Skip to main content
https://pbs.twimg.com/media/FDi4N4oXsAQSZUp.png
Therapeutic drug monitoring ⬆️ infliximab efficacy in RCT. 17.6% improvement in sustained disease control. Consistent across all rheumatic and non-rheumatic diseases. Abstr#1946 #ACR21 @RheumNow https://t.co/D1Ppb58fB8
Richard Conway
09-11-2021
×